Glioblastoma Foundation Announces Drug Development Award
The Glioblastoma Foundation is pleased to announce that Dr. Gregory Riggins, M.D., Ph.D., a world-renowned scientist at Johns Hopkins University School of Medicine, has been named the inaugural recipient of the 2018 Thomas F. Kirby Glioblastoma Foundation Award for glioblastoma drug development. This award will be used to help fund a research project entitled “Development of an improved version of the anti-parasitic agent Mebendazole to treat glioblastoma."
The award was announced during a gala at the Intercontinental hotel in Chicago, Illinois. Family and friends were in attendance to celebrate the life of Thomas F. Kirby and to provide hope for developing a cure for this deadly disease.